Signalling to translation: How signal transduction pathways control the protein synthetic machinery

Biochemical Journal

Volumn 403, Issue 2, 2007, Pages 217-234

  Proud, Christopher G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Mammalian target of rapamycin (mTOR); mRNA; mRNA translation; Ribosome; Signal transduction; Translation factor

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN (MTOR); MRNA; MRNA TRANSLATION; RIBOSOME; TRANSLATION FACTOR;

DISEASES; ENZYME KINETICS; HORMONES; PROTEINS; RNA; SYNTHESIS (CHEMICAL);

SIGNAL TRANSDUCTION;

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOHEXIMIDE; ELONGATION FACTOR 2; GLYCOGEN SYNTHASE KINASE 3; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INITIATION FACTOR 2; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; METHIONINE TRANSFER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RIBOSOME PROTEIN; RIBOSOME RNA; RNA BINDING PROTEIN; S6 KINASE; SEROTONIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MNK; UNCLASSIFIED DRUG;

ATAXIA; CANCER; CELL ENERGY; CELL GROWTH; CELL PROLIFERATION; CELL STRESS; DEMYELINATING DISEASE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE MUTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; RNA BINDING; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; ANIMAL; GENETICS; METABOLISM; PROTEIN BINDING; RIBOSOME;

MAMMALIA;

ANIMALS; HUMANS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RIBOSOMES; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 34247118887     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20070024     Document Type: Review

References (216)

1. Hannan, R. D., Jenkins, A., Jenkins, A. K. and Brandenburger, Y. (2003) Cardiac hypertrophy: a matter of translation. Clin. Exp. Pharmacol. Physiol. 30, 517-527
2. Inoki, K., Corradetti, M. N. and Guan, K. L. (2005) Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 37, 19-24
3. Conlon, I. and Raff, M. (2003) Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression. J. Biol. 2, 7
4. Hinnebusch, A. G. (2000) Mechanism and regulation of methionyl-tRNA binding to ribosomes. In Translational Control of Gene Expression (Sonenberg, N., Hershey, J. W. B. and Mathews, M. B., eds.). pp. 185-243, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
5. Pestova, T. V., Lorsch, J. R. and Hellen, C. U. T. (2006) The mechanism of translation initiation in eukaryotes. In Translational Control in Biology and Medicine (Mathews, M. B., Sonenberg, N. and Hershey, J. W. B., eds.), pp. 87-128, Cold Spring Harbor Laboratory Press
6. Gomez, E., Mohammad, S. S. and Pavitt, G. D. (2002) Characterization of the minimal catalytic domain within elF2B: the guanine-nucleotide exchange factor for translation initiation. EMBO J. 21, 5292-5301
7. Wang, X., Paulin, F. E. M., Campbell, L. E., Gomez, E., O'Brien, K., Morrice, N. and Proud, C. G. (2001) Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the ε subunit and their roles in vivo. EMBO J. 20, 4349-4359
8. Welsh, G. I. and Proud, C. G. (1993) Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor elF-2B. Biochem. J. 294, 625-629
9. Dever, T. E., Dar, A. C. and Sicheri, F. (2006) The elF2α kinases. In Translational Control in Biology and Medicine (Mathews, M. B., Sonenberg, N. and Hershey, J. W. B., eds.), pp. 319-344, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
10. Ron, D. and Harding, H. P. (2006) elF2α phosphorylation in cellular stress responses and disease. In Translational Control in Biology and Medicine (Mathews, M. B., Sonenberg, N. and Hershey, J. W. B., eds.), pp. 345-368, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
11. Hardt, S. E., Tomita, H., Katus, H. A. and Sadoshima, J. (2004) Phosphorylation of eukaryotic translation initiation factor 2Bε by glycogen synthase kinase-3β regulates β-adrenergic cardiac myocyte hypertrophy. Circ. Res. 94, 926-935
12. Kleijn, M., Welsh, G. I., Scheper, G. C., Voorma, H. O., Proud, C. G. and Thomas, A. A. M. (1998) Nerve and epidermal growth factors induce protein synthesis and elF2B activation in PC12 cells. J. Biol. Chem. 273, 5536-5541
13. Welsh, G. I., Miyamoto, S., Proud, C. G. and Safer, B. (1996) T-cell activation leads to rapid stimulation of translation initiation factor elF-2B and inactivation of glycogen synthase kinase-3. J. Biol. Chem. 271, 11410-11413
14. Welsh, G. I. and Proud, C. G. (1992) Regulation of protein synthesis in Swiss 3T3 fibroblasts: rapid activation of the guanine-nucleotide-exchange factor by insulin and growth factors. Biochem. J. 284, 19-23
15. Welsh, G. I., Miller, C. M., Loughlin, A. J., Price, N. T. and Proud, C. G. (1998) Regulation of eukaryotic initiation factor elF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 421, 125-130
16. Leegwater, P. A. J., Vermeulen, G., Koenst, A. A. M., Naidu, S., Mulders, J., Visser, A., Kersbergen, P., Mobach, D., Fonds, D. and van Berkel, C. G. M. (2001) Subunits of the translation initiation factor elF2B are mutated in leukoencephaly with vanishing white matter. Nat. Genet. 29, 383-388
17. Scheper, G. C., Proud, C. G. and Van der Knaap, M. S. (2006) Defective translation initiation causes vanishing of cerebral white matter. Trends Mol. Med. 12, 159-166
18. Fogli, A. and Boespflug-Tanguy, O. (2006) The large spectrum of elF2B-related diseases. Biochem. Soc. Trans. 34, 22-29
19. Li, W., Wang, X., Van der Knaap, M. S. and Proud, C. G. (2004) Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Mol. Cell. Biol. 24, 3295-3306
20. Richardson, J. P., Mohammad, S. S. and Pavitt, G. D. (2004) Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity. Mol. Cell. Biol. 24, 2352-2363
21. Minich, W. B., Balasta, M. L., Goss, D. J. and Rhoads, R. E. (1994) Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor elF-4E: increased cap affinity of the phosphorylated form. Proc. Natl. Acad. Sci. U.S.A. 91, 7668-7672
22. Scheper, G. C., van Kollenburg, B., Hu, J., Luo, Y., Goss, D. J. and Proud, C. G. (2002) Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA. J. Biol. Chem. 277, 3303-3309
23. Slepenkov, S. V., Darzynkiewicz, E. and Rhoads, R. E. (2006) Stopped-flow kinetic analysis of elF4E and phosphorylated elF4E binding to cap analogs and capped oligoribonucleotides: evidence for a one-step binding mechanism. J. Biol. Chem. 281, 14927-14938
24. Gingras, A.-C., Raught, B. and Sonenberg, N. (1999) elF4 translation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68, 913-963
25. Imataka, H., Gradi, A. and Sonenberg, N. (1998) A newly identified N-terminal amino acid sequence of human elF4G binds poly(A)-binding protein and functions in cap-dependent initiation. EMBO J. 17, 7480-7489
26. Harris, T. E., Chi, A., Shabanowitz, J., Hunt, D. F., Rhoads, R. E. and Lawrence, Jr, J. C. (2006) mTOR-dependent stimulation of the association of elF4G and elF3 by insulin. EMBO J. 25, 1659-1668
27. Mader, S., Lee, H., Pause, A. and Sonenberg, N. (1995) The translation initiation factor elF-4E binds to a common motif shared by the translation factor elF-4γ and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 15, 4990-4997
28. Le Sourd, S. F., Boulben, S., Le, B. R., Cormier, P., Morales, J., Belle, R. and Mulner-Lorillon, O. (2006) eEF1B: at the dawn of the 21st century. Biochim. Biophys. Acta 1759, 13-31
29. Jorgensen, R., Merrill, A. R. and Andersen, G. R. (2006) The life and death of translation elongation factor 2. Biochem. Soc. Trans. 34, 1-6
30. Price, N. T., Redpath, N. T., Severinov, K. V., Campbell, D. G., Russell, J. M. and Proud, C. G. (1991) Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes. FEBS Lett. 282, 253-258
31. Carlberg, U., Nilsson, A. and Nygard, O. (1990) Functional properties of phosphorylated elongation factor 2. Eur. J. Biochem. 191, 639-645
32. Ryazanov, A. G. (2002) Elongation factor-2 kinase and its newly discovered relatives. FEBS Lett. 514, 26-29
33. Ryazanov, A. G., Pavur, K. S. and Dorovkov, M. V. (1999) Alpha kinases: a new class of protein kinases with a novel catalytic domain. Curr. Biol. 9, R43-R45
34. Yamaguchi, H., Matsushita, M., Nairn, A. C. and Kuriyan, J. (2001) Crystal structure of the atypical protein kinase domain of a TRP channel with phosphotransferase activity. Mol. Cell 7, 1047-1057
35. Herbert, T. P. and Proud, C. G. (2006) Regulation of translation elongation and the cotranslational protein targeting pathway. In Translational Control in Biology and Medicine (Mathews, M. B., Sonenberg, N. and Hershey, J. W. B., eds.), pp. 601-624, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
36. 2+/calmodulin- independent activity. Biochem. J. 353, 621-626
37. Redpath, N. T. and Proud, C. G. (1993) Cyclic AMP-dependent protein kinase phosphorylates rabbit reticulocyte elongation factor-2 kinase and induces calcium-independent activity. Biochem. J. 293, 31-34
38. Diggle, T. A., Redpath, N. T., Heesom, K. J. and Denton, R. M. (1998) Regulation of protein synthesis elongation factor-2 kinase by cAMP in adipocytes. Biochem. J. 336, 525-529
39. 2+/calmodulin-independent elongation factor 2 kinase activity in IPC-81 cells. FEBS Lett. 444, 97-101
40. Scheetz, A. J., Nairn, A. C. and Constantine-Paton, M. (2000) NMDA-mediated control of protein synthesis at developing synapses. Nat. Neurosci. 3, 1-7
41. Scheetz, A. J., Nairn, A. C. and Constantine-Paton, M. (1997) N-methyl-D-aspartate receptor activation and visual activity induce elongation factor-2 phosphorylation in amphibian tecta: a role for N-methyl-D-aspartate receptors in controlling protein synthesis. Proc. Natl. Acad. Sci. U.S.A. 94, 14770-14775
42. Walden, W. E. and Thach, R. E. (1986) Translational control of gene expression in a normal fibroblast: characterization of a subclass of mRNAs with unusual kinetic properties. Biochemistry 25, 2033-2041
43. Carroll, M., Warren, O., Fan, X. and Sossin, W. S. (2004) 5-HT stimulates eEF2 dephosphorylation in a rapamycin-sensitive manner in Aplysia neurites. J. Neurochem. 90, 1464-1476
44. Inamura, N., Nawa, H. and Takei, N. (2005) Enhancement of translation elongation in neurons by brain-derived neurotrophic factor: implications for mammalian target of rapamycin signaling. J. Neurochem. 95, 1438-1445
45. Klann, E. and Richter, J. D. (2006) Protein synthesis and translational control in synaptic plasticity and learning and memory. In Translational Control in Biology and Medicine (Mathews, M. B., Sonenberg, N. and Hershey, J. W. B., eds.), pp. 485-506, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
46. Maurin, A. C., Jousse, C., Averous, J., Parry, L., Bruhat, A., Cherasse, Y., Zeng, H., Zhang, Y., Harding, H. P., Ron, D. and Fafournoux, P. (2005) The GCN2 kinase biases feeding behavior to maintain amino acid homeostasis in omnivores. Cell Metab. 1, 273-277
47. Avruch, J., Belham, C., Weng, Q., Hara, K. and Yonezawa, K. (2001) The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26, 115-154
48. Holz, M. K., Ballif, B. A., Gygi, S. P. and Blenis, J. (2005) mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123, 569-580
49. 422 is modulated by S6 kinases. EMBO J. 23, 1761-1769
50. RSK1 and p70 S6 kinase. EMBO J. 20, 4371-4379
51. Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M. and Sonenberg, N. (2006) The mTOR/PI3K and MAPK pathways converge on elF4B to control its phosphorylation and activity. EMBO J. 25, 2781-2791
52. Wilhelm, J. E. and Smibert, C. A. (2005) Mechanisms of translational regulation in Drosophila. Biol. Cell 97, 235-252
53. Brazil, D. P., Yang, Z. Z. and Hemmings, B. A. (2004) Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233-242
54. Cully, M., You, H., Levine, A. J. and Mak, T. W. (2006) Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184-192
55. Cohen, P. and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776
56. Cohen, P. and Goedert, M. (2004) GSK3 inhibitors: development and therapeutic potential. Nat. Rev. Drug Discov. 3, 479-487
57. 212: potential role for DYRK as a GSK3 priming kinase. Biochem. J. 355, 609-615
58. Williams, D. D., Pavitt, G. D. and Proud, C. G. (2001) Characterisation of the initiation factor elF2B and its regulation in Drosophila melanogaster. J. Biol. Chem. 276, 3733-3742
59. Pap, M. and Cooper, G. M. (2001) Role of translation initiation factor 2B in the control of cell survival by the phosphatidyl inositol 3-kinase/Akt/glycogen synthase kinase 3β signaling pathway. Mol. Cell. Biol. 22, 578-586
60. Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M. and Ron, D. (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099-1108
61. 535 in the ε-subunit of eukaryotic initiation factor 2B is insufficient for the activation of elF2B by insulin. Biochem. J. 367, 475-481
62. Campbell, L. E., Wang, X. and Proud, C. G. (1999) Nutrients differentially modulate multiple translation factors and their control by insulin. Biochem. J. 344, 433-441
63. Kleijn, M. and Proud, C. G. (2000) The activation of eukaryotic initiation factor (elF)2B by growth factors in PC12 cells requires MEK/Erk signalling. FEBS Lett. 476, 262-265
64. Quevedo, C., Alcazar, A. and Salinas, M. (2000) Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal cells. J. Biol. Chem. 275, 19192-19197
65. Quevedo, C., Salinas, M. and Alcazar, A. (2003) Initiation factor 2B activity is regulated by protein phosphatase 1, which is activated by the mitogen-activated protein kinase-dependent pathway in insulin-like growth factor 1-stimulated neuronal cells. J. Biol. Chem. 278, 16579-16586
66. Abraham, R. T. (2004) PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways. DNA Repair 3, 883-887
67. Wullschleger, S., Loewith, R. and Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484
68. Brunn, G. J., Hudson, C. C., Sekulic, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C. and Abraham, R. T. (1997) Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277, 99-101
69. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H. and Sabatini, D. M. (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl. Acad. Sci. U.S.A. 95, 1432-1437
70. Wang, X., Beugnet, A., Murakami, M., Yamanaka, S. and Proud, C. G. (2005) Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol. Cell. Biol. 25, 2558-2572
71. McMahon, L. P., Choi, K. M., Lin, T. A., Abraham, R. T. and Lawrence, Jr, J. C. (2002) The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol. Cell. Biol. 22, 7428-7438
72. Kimball, S. R. and Jefferson, L. S. (2006) Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J. Nutr. 136, 227S-231S
73. Sarbassov, D. D., Ali, S. M. and Sabatini, D. M. (2005) Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603
74. Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J. H., Hsu, P. P., Bagley, A. F., Markhard, A. L. and Sabatini, D. M. (2006) Prolonged rapamycin treatment inhibits mT0RC2 assembly and Akt/PKB. Mol. Cell 22, 159-168
75. Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Ruegg, M. A., Hall, A. and Hall, M. N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128
76. Nojima, H., Tokunaga, C., Eguchi, S., Oshiro, N., Hidayat, S., Yoshino, K., Hara, K., Tanaka, J., Avruch, J. and Yonezawa, K. (2003) The mTOR partner, raptor, binds the mTOR substrates, p70 S6 kinase and 4E-BP1, through their TOS (TOR signaling) motifs. J. Biol. Chem. 278, 15461-15464
77. Schalm, S. S., Fingar, D. C., Sabatini, D. M. and Blenis, J. (2003) TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13, 797-806
78. 473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J. Biol. Chem. 280, 40406-40416
79. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J. and Su, B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137
80. Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101
81. Manning, B. D. and Cantley, L. C. (2003) Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28, 573-576
82. Manning, B. D. and Cantley, L. C. (2003) United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochem. Soc. Trans. 31, 573-578
83. Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. and Avruch, J. (2005) Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702-713
84. Smith, E. M., Finn, S. G., Tee, A. R., Browne, G. J. and Proud, C. G. (2005) The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses. J. Biol. Chem. 280, 18717-18727
85. Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S. and Yonezawa, K. (2006) Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase. Oncogene 25, 6361-6372
86. Kwiatkowski, D. J. and Manning, B. D. (2005) Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum. Mol. Genet. 14, R251-R258
87. Easton, J. B. and Houghton, P. J. (2006) mTOR and cancer therapy. Oncogene 25, 6436-6446
88. Jozwiak, J. (2006) Hamartin and tuberin: working together for tumour suppression. Int. J. Cancer 118, 1-5
89. Altomare, D. A. and Testa, J. R. (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455-7464
90. Guertin, D. A. and Sabatini, D. M. (2005) An expanding role for mTOR in cancer. Trends Mol. Med. 11, 353-361
91. Sabatini, D. M. (2006) mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6, 729-734
92. Thomas, G. V. (2006) mTOR and cancer: reason for dancing at the crossroads? Curr. Opin. Genet. Dev. 16, 78-84
93. Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C. and Blenis, J. (2002) Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. U.S.A. 99, 13571-13576
94. Long, X., Ortiz-Vega, S., Lin, Y. and Avruch, J. (2005) Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J. Biol. Chem. 280, 23433-23436
95. Gingras, A.-C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R. and Sonenberg, N. (1999) Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13, 1422-1437
96. Mothe-Satney, I., Brunn, G. J., McMahon, L. P., Capaldo, C. T., Abraham, R. T. and Lawrence, J. C. (2000) Mammalian target of rapamycin-dependent phosphorylation of PHAS-1 in four (S/T)P sites detected by phospho-specific antibodies. J. Biol. Chem. 275, 33836-33843
97. Wang, X., Li, W., Parra, J.-L., Beugnet, A. and Proud, C. G. (2003) The C-terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation. Mol. Cell. Biol. 23, 1546-1557
98. Ferguson, G., Mothe-Satney, I. and Lawrence, Jr, J. C. (2003) Ser-64 and Ser-111 in PHAS-I are dispensable for insulin-stimulated dissociation from elF4E. J. Biol. Chem. 278, 47459-47465
99. Schalm, S. S. and Blenis, J. (2002) Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632-639
100. Tee, A. R. and Proud, C. G. (2002) Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif. Mol. Cell. Biol. 22, 1674-1683
101. Weng, Q.-P., Kozlowski, M., Belham, C., Zhang, A., Comb, M. J. and Avruch, J. (1998) Regulation of the p70 S6 kinase by phosphorylation in vivo: analysis using site-specific anti-phosphopeptide antibodies. J. Biol. Chem. 273, 16621-16629
102. Haghighat, A., Mader, S., Pause, A. and Sonenberg, N. (1995) Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14, 5701-5709
103. Blackshear, P. J., Stumpo, D. J., Carballo, E. and Lawrence, J. C. (1997) Disruption of the gene encoding the mitogen-regulated translational modulator PHAS-I in mice. J. Biol. Chem. 272, 31510-31514
104. Tsukiyama-Kohara, K., Poulin, F., Kohara, M., DeMaria, C. T., Cheng, A., Wu, Z., Gingras, A. C., Katsume, A., Elchebly, M., Spiegelman, B. M. et al. (2001) Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat. Med. 7, 1128-1132
105. Banko, J. L., Poulin, F., Hou, L., DeMaria, C. T., Sonenberg, N. and Klann, E. (2005) The translation repressor 4E-BP2 is critical for elF4F complex formation, synaptic plasticity, and memory in the hippocampus. J. Neurosci. 25, 9581-9590
106. Averous, J. and Proud, C. G. (2006) When translation meets transformation: the mTOR story. Oncogene 25, 6423-6435
107. Mamane, Y., Petroulakis, E., Lebacquer, O. and Sonenberg, N. (2006) mTOR, translation initiation and cancer. Oncogene 25, 6416-6422
108. Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C. and Pandolfi, P. P. (2004) The translation factor elF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat. Med. 10, 484
109. Wendel, H. G., De Stanchina, E., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J. and Lowe, S. W. (2004) Survival signalling by Akt and elF4E in oncogenesis and cancer therapy. Nature 428, 332-337
110. Li, S., Takasu, T., Perlman, D. M., Peterson, M. S., Burrichter, D., Avdulov, S., Birterman, P. B. and Polunovsky, V. A. (2003) Translation factor elF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release. J. Biol. Chem. 278, 3015-3022
111. Tan, A., Bitterman, P., Sonenberg, N., Peterson, M. and Polunovsky, V. (2000) Inhibition of Myc-dependent apoptosis by euakryotic translation initiation factor 4E requires cyclin D1. Oncogene 19, 1437-1447
112. Herbert, T. P., Fahraeus, R., Prescott, A., Lane, D. P. and Proud, C. G. (2000) Rapid induction of apoptosis mediated through peptides that bind initiation factor elF4E. Curr. Biol. 10, 793-796
113. Rosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N. and Schmidt, E. V. (1993) Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol. 13, 7358-7363
114. Shantz, L. M., Coleman, C. S. and Pegg, A. E. (1996) Expression of ornithine decarboxylase dominant negative mutant reverses eukaryotic initiation factor-4E induced cell transformation. Cancer Res. 56, 5136-5140
115. Shantz, L. M. and Pegg, A. E. (1994) Regulation of ornithine decarboxylase (ODC) expression by translation initiation factor elF-4E. FASEB J. 8, A1309
116. Kevil, C. G., De Benedetti, A., Payne, D. K., Coe, L. L., Laroux, F. S. and Alexander, J. S. (1996) Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int. J. Cancer 65, 785-790
117. Jiang, Y. and Muschel, R. J. (2002) Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. Cancer Res. 62, 1910-1914
118. Graff, J. R. and Zimmer, S. G. (2003) Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein elF-4E selectively enhances translation of metastasis-related mRNAs. Clin. Exp. Metastasis 20, 265-273
119. Fukuchi-Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., Ekimoto, J. and Igarashi, K. (1997) Malignant transformation by overproduction of translation initiation factor elF4G. Cancer Res. 57, 5041-5044
120. Rousseau, D., Kaspar, R., Rosenwald, I., Gehrke, L. and Sonenberg, N. (1996) Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 messenger-RNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. U.S.A. 93, 1065-1070
121. Culjkovic, B., Topisirovic, I., Skrabanek, I., Ruiz-Gutierrez, M. and Borden, K. L. (2005) elF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′UTR. J. Cell Biol. 169, 245-256
122. Strudwick, S. and Borden, K. L. (2002) The emerging roles for translation factor elF4E in the nucleus. Differentiation 70, 10-22
123. -/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol. 24, 3112-3124
124. S6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17, 6649-6659
125. Montagne, J., Stewart, M. J., Stacker, H., Hafen, E., Kozma, S. C. and Thomas, G. (1999) Drosophila S6 kinase: a regulator of cell size. Science 285, 2126-2129
126. Ruvinsky, I., Sharon, N., Lerer, T., Cohen, H., Stolovich-Rain, M., Nir, T., Dor, Y., Zisman, P. and Meyuhas, O. (2005) Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19, 2199-2211
127. Pende, M., Kozma, S. C., Jaquet, M., Oorschot, V., Burcelin, R., Le Marchand-Brustel, Y., Klumperman, J., Thorens, B. and Thomas, G. (2000) Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408, 994-997
128. Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R. et al. (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213-223
129. Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J. and Thomas, G. (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205
130. 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes: evidence for involvement of p70 S6 kinase. Circ. Res. 81, 176-186
131. Shioi, T., McMullen, J. R., Tarnavski, O., Converso K., Sherwood, M. C., Manning, W. J. and Izumo, S. (2003) Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107, 1664-1670
132. McMullen, J. R., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M. C., Dorfman, A. L., Longnus, S., Pende, M., Martin, K. A., Blenis, J. et al. (2004) Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy. Mol. Cell. Biol. 24, 6231-6240
133. Redpath, N. T., Foulstone, E. J. and Proud, C. G. (1996) Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J. 15, 2291-2297
134. Browne, G. J. and Proud, C. G. (2004) A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol. Cell. Biol. 24, 2986-2997
135. Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A. and Cohen, P. (1996) Molecular basis for the substrate specificity of protein kinase B: comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399, 333-338
136. Knebel, A., Morrice, N. and Cohen, P. (2001) A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38δ. EMBO J. 20, 4360-4369
137. Knebel, A., Haydon, C. E., Morrice, N. and Cohen, P. (2002) Stress-induced regulation of eEF2 kinase by SB203580-sensitive and -insensitive pathways. Biochem. J. 367, 525-532
138. Meyuhas, O. and Hornstein, E. (2000) Translational control of TOP mRNAs. In Translational Control of Gene Expression (Sonenberg, N., Hershey, J. W. B. and Mathews, M. B., eds.), pp. 671-693, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
139. Jefferies, H. B. J. and Thomas, G. (1994) Elongation factor-1α mRNA is selectively translated following mitogenic stimulation. J. Biol. Chem. 269, 4367-4372
140. Jefferies, H. B. J., Reinhard, G., Kozma, S. C. and Thomas, G. (1994) Rapamycin selectively represses translation of the 'polypyrimidine tract' mRNA family. Proc. Natl. Acad. Sci. U.S.A. 91, 4441-4445
141. Avni, D., Biberman, Y. and Meyuhas, O. (1997) The 5′ terminal oligopyrimidine tract confers translational control on TOP mRNAs in a cell type and sequence context dependent manner. Nucleic Acids Res. 25, 995-1001
142. Hornstein, E., Git, A., Braunstein, I., Avni, D. and Meyuhas, O. (1999) The expression of poly(A)-binding protein gene is translationally regulated in a growth-dependent fashion through a 5′-terminal oligopyrimidine tract motif. J. Biol. Chem. 274, 1708-1714
143. Tang, H., Hornstein, E., Stolovich, M., Levy, G., Livingstone, M., Templeton, D., Avruch, J. and Meyuhas, O. (2001) Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signalling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol. Cell. Biol. 21, 8671-8683
144. Mayer, C. and Grummt, I. (2006) Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 25, 6384-6391
145. Schmidt, E. V. (1999) The role of c-Myc in cellular growth control. Oncogene 18, 2988-2996
146. Corradetti, M. N. and Guan, K. L. (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25, 6347-6360
147. Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C. and Thomas, G. (2001) Mammalian TOR: a homeostatic ATP sensor. Science 294, 1102-1105
148. Hardie, D. G., Scott, J. W., Pan, D. A. and Hudson, E. R. (2003) Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 546, 113-120
149. Inoki, K., Zhu, T. and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590
150. Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W. and Kaelin, Jr, W. G. (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18, 2893-2904
151. Corradetti, M. N., Inoki, K. and Guan, K. L. (2005) The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway. J. Biol. Chem. 280, 9769-9772
152. Choo, A. Y., Roux, P. P. and Blenis, J. (2006) Mind the GAP: Wnt steps onto the mTORCI train. Cell 126, 834-836
153. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K. et al. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968
154. Browne, G. J., Finn, S. G. and Proud, C. G. (2004) Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. 279, 12220-12231
155. Horman, S., Beauloye, C., Vertommen, D., Vanoverschelde, J. L., Hue, L. and Rider, M. H. (2003) Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J. Biol. Chem. 278, 41970-41976
156. Horman, S., Browne, G. J., Krause, U., Patel, J. V., Vertommen, D., Bertrand, L., Lavoinne, A., Hue, L., Proud, C. G. and Rider, M. H. (2002) Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12, 1419-1423
157. McLeod, L. E. and Proud, C. G. (2002) ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signalling. FEBS Lett. 531, 448-452
158. Terai, K., Hiramoto, Y., Masaki, M., Sugiyama, S., Kuroda, T., Hori, M., Kawase, I. and Hirota, H. (2005) AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol. Cell. Biol. 25, 9554-9575
159. Connolly, E., Braunstein, S., Formenti, S. and Schneider, R. J. (2006) Hypoxia inhibits protein synthesis through a 4E-BP1 and elongation factor 2 kinase pathway controlled by mTOR and uncoupled in breast cancer cells. Mol. Cell. Biol. 26, 3955-3965
160. Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B. and Simon, M. C. (2006) Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol. Cell 21, 521-531
161. Bi, M., Naczki, C., Koritzinsky, M., Fels, D., Blais, J., Hu, N., Harding, H., Novoa, I., Varia, M., Raleigh, J. et al. (2005) ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J. 24, 3470-3481
162. Koritzinsky, M., Magagnin, M. G., van den Buecken, T., Seigneuric, R., Savelkouls, K., Dostie, J., Pyronnet, S., Kaufman, R. J., Weppler, S. A., Voncken, J. W. et al. (2006) Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 25, 1114-1125
163. Li, Y., Inoki, K., Vacratsis, P. and Guan, K. L. (2003) The p38 and MK2 kinase cascade phosphorylates tuberin, the tuberous sclerosis 2 gene product, and enhances its interaction with 14-3-3. J. Biol. Chem. 278, 13663-13671
164. Dean, J. L., Sully, G., Clark, A. R. and Saklatvala, J. (2004) The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell. Signalling 16, 1113-1121
165. Ronkina, N., Kotlyarov, A., Dittrich-Breiholz, O., Kracht, M., Hitti, E., Milarski, K., Askew, R., Marusic, S., Lin, L. L., Gaestel, M. and Telliez, J. B. (2006) The MAPKAP kinases MK2 and MK3 cooperate in stimulation of TNF biosynthesis and stabilization of p38 MAPK. Mol. Cell. Biol. 27, 170-181
166. Rousseau, S., Morrice, N., Peggie, M., Campbell, D. G., Gaestel, M. and Cohen, P. (2002) Inhibition of SAPK2a/p38 prevents hnRNP AO phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J. 21, 6505-6514
167. Tietz, A. B., Malo, A., Diebold, J., Kotlyarov, A., Herbst, A., Kolligs, F. T., Brandt-Nedelev, B., Halangk, W., Gaestel, M., Goke, B. and Schafer, C. (2006) Gene deletion of MK2 inhibits TNF-α and IL-6 and protects against cerulein-induced pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1298-G1306
168. Andersson, K. and Sundler, R. (2006) Posttranscriptional regulation of TNFα expression via eukaryotic initiation factor 4E (elF4E) phosphorylation in mouse macrophages. Cytokine 33, 52-57
169. Buxadé, M., Parra, J. L., Rousseau, S., Shpiro, N., Marquez, R., Morrice, N., Bain, J., Espel, E. and Proud, C. G. (2005) The Mnks are novel components in the control of TNFα biosynthesis and phosphorylate and regulate hnRNP A1. Immunity 23, 177-189
170. Fukunaga, R. and Hunter, T. (1997) Mnk1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16, 1921-1933
171. Wang, X., Flynn, A., Waskiewicz, A. J., Webb, B. L. J., Vries, R. G., Baines, I. A., Cooper, J. and Proud, C. G. (1998) The phosphorylation of eukaryotic initiation factor elF4E in response to phorbol esters, cell stresses and cytokines is mediated by distinct MAP kinase pathways. J. Biol. Chem. 273, 9373-9377
172. Waskiewicz, A. J., Flynn, A., Proud, C. G. and Cooper, J. A. (1997) Mitogen-activated kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909-1920
173. Pyronnet, S., Imataka, H., Gingras, A. C., Fukunaga, R., Hunter, T. and Sonenberg, N. (1999) Human eukaryotic translation initiation factor 4G (elF4G) recruits Mnk1 to phosphorylate elF4E. EMBO J. 18, 270-279
174. Ueda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S. and Fukunaga, R. (2004) Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol. Cell. Biol 24, 6539-6549
175. O'Loghlen, A., Gonzalez, V. M., Pineiro, D., Perez-Morgado, M. I., Salinas, M. and Martin, M. E. (2004) Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1. Exp. Cell Res. 299, 343-355
176. Scheper, G. C., Parra, J.-L., Wilson, M. L., van Kollenburg, B., Vertegaal, A. C. O., Han, Z.-G. and Proud, C. G. (2003) The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization. Mol. Cell. Biol. 23, 5692-5705
177. Slentz-Kesler, K., Moore, J. T., Lombard, M., Zhang, J., Hollingsworth, R. and Weiner, M. P. (2000) Identification of the human Mnk2 gene (MKNK2) through protein interaction with estrogen receptor β. Genomics 69, 63-71
178. Parra, J. L., Buxadé, M. and Proud, C. G. (2005) Features of the catalytic domains and C termini of the MAPK signal-integrating kinases Mnk1 and Mnk2 determine their differing activities and regulatory properties. J. Biol. Chem. 280, 37623-37633
179. Scheper, G. C., Morrice, N. A., Kleijn, M. and Proud, C. G. (2001) The MAP kinase signal-integrating kinase Mnk2 is an elF4E kinase with high basal activity in mammalian cells. Mol. Cell. Biol. 21, 743-754
180. Scheper, G. C. and Proud, C. G. (2002) Does phosphorylation of the cap-binding protein elF4E play a role in translation initiation? Eur. J. Biochem. 269, 5350-5359
181. Lachance, P. E. D., Miron, M., Raught, B., Sonenberg, N. and Lasko, P. (2002) Phosphorylation of eukaryotic translation initiation factor 4E is critical for growth. Mol. Cell. Biol. 22, 1656-1663
182. Dyer, J. R., Michel, S., Lee, W., Castellucci, V. F., Wayne, N. L. and Sossin, W. S. (2003) An activity-dependent switch to cap-independent translation triggered by elF4E dephosphorylation. Nat. Neurosci. 6, 219-220
183. Walsh, D. and Mohr, I. (2004) Phosphorylation of elF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev. 18, 660-672
184. Cuesta, R., Xi, Q. and Schneider, R. J. (2000) Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex elF4F. EMBO J. 19, 3465-3474
185. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F. and Kollias, G. (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 10, 387-398
186. Han, J., Brown, T. and Beutler, B. (1990) Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171, 465-475
187. Neininger, A., Kontoyiannis, D., Kotlyarov, A., Winzen, R., Eckert, R., Volk, H. D., Holtmann, H., Kollias, G. and Gaestel, M. (2002) MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277, 3065-3068
188. Barreau, C., Paillard, L. and Osborne, H. B. (2005) AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 33, 7138-7150
189. Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H. D. and Gaestel, M. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat. Cell Biol. 1, 94-97
190. Hegen, M., Gaestel, M., Nickerson-Nutter, C. L., Lin, L. L. and Telliez, J. B. (2006) MAPKAP kinase 2-deficient mice are resistant to collagen-induced arthritis. J. Immunol. 177, 1913-1917
191. 178, a site required for 14-3-3 binding. J. Biol. Chem. 279, 10176-10184
192. Hitti, E., Iakovleva, T., Brook, M., Deppenmeier, S., Gruber, A. D., Radzioch, D., Clark, A. R., Blackshear, P. J., Kotlyarov, A. and Gaestel, M. (2006) Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26, 2399-2407
193. Bollig, F., Winzen, R., Gaestel, M., Kostka, S., Resch, K. and Holtmann, H. (2003) Affinity purification of ARE-binding proteins identifies polyA-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization. Biochem. Biophys. Res. Commun. 301, 665-670
194. Allemand, E., Guil, S., Myers, M., Moscat, J., Caceres, J. R and Krainer, A. R. (2005) Regulation of heterogeneous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc. Natl. Acad. Sci. U.S.A. 102, 3605-3610
195. Anderson, P. and Kedersha, N. (2006) RNA granules. J. Cell Biol. 172, 803-808
196. Guil, S., Long, J. C. and Cáceres, J. F. (2006) hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol. Cell. Biol. 26, 5744-5758
197. Jauch, R., Jakel, S., Netter, C., Schreiter, K., Aicher, B., Jackle, H. and Wahl, M. C. (2005) Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site. Structure 13, 1559-1568
198. Roux, P. P. and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344
199. Rolfe, M., McLeod, L. E., Pratt, P. F. and Proud, C. G. (2005) Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem. J. 388, 973-984
200. Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P. and Blenis, J. (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 101, 13489-13494
201. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. and Pandolfi, P. P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk: implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193
202. Ballif, B. A., Roux, P. P., Gerber, S. A., Mackeigan, J. P., Blenis, J. and Gygi, S. P. (2005) Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc. Natl. Acad. Sci. U.S.A. 102, 667-672
203. Wang, L. and Proud, C. G. (2002) Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes. FEBS Lett. 531, 285-289
204. Patel, J., McLeod, L. E., Vries, R. G., Flynn, A., Wang, X. and Proud, C. G. (2002) Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. Eur. J. Biochem. 269, 3076-3085
205. Scheuner, D., Song, B., McEwen, E., Liu, C., Laybutt, R., Gillespie, P., Saunders, T., Bonners-Weir, S. and Kaufman, R. J. (2001) Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7, 1165-1176
206. Traugh, J. A. (2001) Insulin, phorbol ester and serum regulate the elongation phase of protein synthesis. Prog. Mol. Subcell. Biol. 26, 33-48
207. Herbert, T. P., Kilhams, G. R., Batty, I. H. and Proud, C. G. (2000) Distinct signalling pathways mediate insulin and phorbol ester-stimulated elF4F assembly and protein synthesis in HEK 293 cells. J. Biol. Chem. 275, 11249-11256
208. Colthurst, D. R., Campbell, D. G. and Proud, C. G. (1987) Structure and regulation of eukaryotic initiation factor elR-2: sequence of the site in the α subunit phosphorylated by the haem-controlled repressor and by the double-stranded RNA-activated inhibitor. Eur. J. Biochem. 166, 357-363
209. Joshi, B., Cai, A. L., Keiper, B. D., Minich, W. B., Mendez, R., Beach, C. M., Stolarski, R., Darzynkiewicz, E. and Rhoads, R. E. (1995) Phosphorylation of eukaryotic protein synthesis initiation factor 4E at serine 209. J. Biol. Chem. 270, 14597-14603
210. Raught, B., Gingras, A. C., Gygi, S. P., Imataka, H., Morino, S., Gradi, A., Aebersold, R. and Sonenberg, N. (2000) Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI. EMBO J. 19, 434-444
211. Krieg, J., Olivier, A. R. and Thomas, G. (1988) Analysis of 40 S ribosomal protein S6 phosphorylation during the mitogenic response. Methods Enzymol. 164, 575-581
212. Fadden, P., Haystead, T. A. J. and Lawrence, J. C. (1997) Identification of the phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes. J. Biol. Chem. 272, 10240-10247
213. Fadden, P., Haystead, T. A. and Lawrence, J. C. (1998) Phosphorylation of the translational regulator, PHAS-I, by protein kinase CK2. FEBS Lett. 435, 105-109
214. Heesom, K., Gampel, A., Mellor, H. and Denton, R. M. (2001) Cell cycle-dependent phosphorylation of the translational repressor elF4E binding protein-1 (4E-BP1). Curr. Biol. 11, 1374-1379
215. Merrick, W. C. and Nyborg, J. (2007) The protein biosynthesis elongation cycle. In Translational Control of Gene Expression (Sonenberg, N., Hershey, J. W. B. and Mathews, M. B., eds.), pp. 89-125, Cold Spring Harbor Laboratory Press, Cold Spring Harbor
216. Le Bacquer, L., Petroulakis, E., Paglialunga, S., Poulin, F., Richard, D., Cianflone, K. and Sonenberg, N. (2007) Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J. Clin. Invest. 117, 387-396